NDC 58468-0040

Fabrazyme 5 mg per 1 mL injection, powder, lyophilized, for solution

On the label: Genzyme Corporation.

United States: 4Ireland: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Genzyme CorporationFramingham, MA, United StatesMakes the active ingredient and tests it Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action
Genzyme CorporationFramingham, MA, United StatesMakes the active ingredient and tests it Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action
Genzyme CorporationFramingham, MA, United StatesMakes the active ingredient Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action
Genzyme CorporationFramingham, MA, United StatesMakes the active ingredient and tests it Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action
Genzyme Ireland LimitedWaterford, IrelandMakes it, tests it, packages it and labels it Problems found, fixed voluntarilyFeb 25, 2022 · 7 inspections
Genzyme CorporationNorthborough, MA, United StatesPackages it and labels it No problems foundAug 14, 2025 · 6 inspections
Genzyme CorporationFramingham, MA, United StatesTests it Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action

Product details

Generic drug
Agalsidase Beta: every company that makes it
Form
injection, powder, lyophilized, for solution, intravenous
Strength
5 mg per 1 mL
Approval
BLA BLA103979
On the market since
Dec 17, 2008
Package NDCs
58468-0040-1
Official label
DailyMed (National Library of Medicine), updated Aug 22, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?